Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Takeda Pharmaceutical Ltd ADR
(NY:
TAK
)
13.52
-0.18 (-1.31%)
Streaming Delayed Price
Updated: 1:14 PM EDT, Jul 18, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Takeda Pharmaceutical Ltd ADR
< Previous
1
2
...
10
11
12
13
14
15
16
17
Next >
Takeda's Breakthrough Blood Cancer Drug Flunks In Phase 3 Study
September 02, 2021
Takeda Pharmaceutical Co Ltd (NYSE: TAK) announced topline data from the Phase 3 PANTHER study evaluating pevonedistat in blood cancer indications. The trial did...
Via
Benzinga
The Daily Biotech Pulse: Assembly Bio Halts HBV Study, Moderna Initiates Submission For COVID-19 Booster Dose, FDA Nod For BeiGene, Tiziana Out-Licenses Foralumab
September 02, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 1) AbbVie Inc. (NASDAQ: ABBV...
Via
Benzinga
Exposures
COVID-19
Product Safety
Takeda Provides Update on Phase 3 PANTHER (Pevonedistat-3001) Trial
September 01, 2021
From
Takeda Pharmaceutical Company Limited
Via
Business Wire
Analyzing Takeda Pharmaceutical's Unusual Options Activity
August 03, 2021
Shares of Takeda Pharmaceutical (NYSE:TAK) saw some unusual ...
Via
Benzinga
Moderna Reviews Contamination In Vaccine Lot Distributed In Japan
September 01, 2021
Moderna, Inc. (NASDAQ: MRNA) found itself in a controversy after Japan suspended the use of about 2.6 million doses of the company's COVID-19 vaccine following reports of...
Via
Benzinga
Exposures
COVID-19
UK's NICE Rejects Johnson & Johnson's Darzalex Regime For Newly Diagnosed Myeloma
August 30, 2021
New guidance from the National Institute for Health and Care Excellence (NICE) has rejected a combination regimen based on Johnson & Johnson's (NYSE: JNJ)...
Via
Benzinga
Moderna Withdraws Additional COVID-19 Shots In Japan: What You Need To Know
August 30, 2021
After receiving reports on more contaminated vials and two deaths, Japan has suspended another million doses of Moderna Inc's (NASDAQ: MRNA) COVID-19...
Via
Benzinga
Topics
Death
Exposures
COVID-19
Death
Suspected Metallic Particles Behind Moderna's Japan COVID-19 Jab Contamination: Reuters
August 27, 2021
Metallic particle is believed to be a contaminant found in a batch of Moderna Inc's (NASDAQ: MRNA) COVID-19 vaccines delivered to Japan, Japanese public broadcaster...
Via
Benzinga
Exposures
COVID-19
Exelixis - Takeda's Cabometyx Scores Approval In Japan For Kidney Cancer
August 26, 2021
Exelixis Inc's (NASDAQ: EXEL) collaborating partner Takeda Pharmaceutical Co Ltd (NYSE: TAK) and Ono Pharmaceutical Co Ltd have received...
Via
Benzinga
Understanding Takeda Pharmaceutical's Unusual Options Activity
July 30, 2021
Takeda Pharmaceutical (NYSE:TAK) shares experienced unusual ...
Via
Benzinga
Moderna Withdraws 1.6M COVID-19 Vaccine Doses In Japan Over Contamination Concerns
August 26, 2021
More than a million doses of Moderna Inc’s (NASDAQ: MRNA) coronavirus vaccine have been taken out of circulation in Japan after reports of contamination emerged, Nikkei Asia...
Via
Benzinga
Exposures
COVID-19
BioLife Plasma Services Opens First All-Electric Plasma Donation Center
August 18, 2021
From
Takeda Pharmaceutical Company Limited
Via
Business Wire
Friday the Thirteenth
August 13, 2021
The stock week in points eastward was mixed. The USA markets face a bear correction.
Via
Talk Markets
Takeda To Lead Finch-Partnered Microbiome IBD Drug
August 10, 2021
Finch Therapeutics Group Inc (NASDAQ: FNCH) announced that Takeda Pharmaceutical Company Limited (NYSE: TAK) has elected to take the lead on the development of FIN...
Via
Benzinga
Why BioCryst Pharmaceuticals Rose 8% on Thursday
August 05, 2021
The company's first commercial drug launch keeps exceeding expectations.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Product Safety
Final Results from the Longest Hereditary Angioedema Study of Active Treatment Duration Conducted to Date Support the Sustained Safety and Efficacy of TAKHZYRO® (lanadelumab) Injection for Long-Term Prevention of Hereditary Angioedema Attacks
August 05, 2021
From
Takeda Pharmaceutical Company Limited
Via
Business Wire
Know When To Hold 'Em, Know When To Fold 'Em ...
August 02, 2021
A long Monday list identifying some sensible and some impenetrable moves behind today's market in our stocks.
Via
Talk Markets
Takeda Receives Decision by the Irish Tax Appeals Commission Relating to Tax Assessment on Break Fee Shire Received from AbbVie
August 01, 2021
From
Takeda Pharmaceutical Company Limited
Via
Business Wire
Takeda Delivers Solid First Quarter FY2021 Results, Positioning Company to Accelerate Topline Growth and Continued Pipeline Progress
July 30, 2021
From
Takeda Pharmaceutical Company Limited
Via
Business Wire
Takeda and Frazier Healthcare Partners Announce Collaboration to Launch HilleVax, Inc. to Develop Clinical Stage Norovirus Vaccine Candidate
July 29, 2021
From
Takeda Pharmaceutical Company Limited
Via
Business Wire
Full News Day
July 28, 2021
The US greatly increased its exports of liquified natural gas in the first half-year, to 9.6 billion cubic feet per day, a rise of 42% from a year earlier.
Via
Talk Markets
Topics
Energy
Exposures
Fossil Fuels
Takeda's Narcolepsy Candidate Gets FDA Breakthrough Therapy Tag
July 28, 2021
The FDA has granted Breakthrough Therapy Designation to Takeda Pharmaceutical Company Limited's (NYSE: TAK) TAK-994 for excessive daytime sleepiness (EDS...
Via
Benzinga
Exposures
Product Safety
U.S. Food and Drug Administration Grants Breakthrough Therapy Designation to Takeda’s Investigational Compound, TAK-994, an Oral Orexin Agonist in Clinical Development for Narcolepsy Type 1 (NT1)
July 28, 2021
From
Takeda Pharmaceutical Company Limited
Via
Business Wire
XBIO Stock: Xenetic Soars on Private Placement Announcement
July 26, 2021
XBIO stock is continuing a heck of a week. Just days after it was boosted by Takeda's expansion news, it's looking at a big private sale.
Via
InvestorPlace
Containment Plan
July 23, 2021
Today the US decided to cut China risks.
Via
Talk Markets
“Claw-Back” day
July 20, 2021
The rally was just as irrational as the selloff.
Via
Talk Markets
Takeda Data at ISTH 2021 Highlight the Benefits of Prophylaxis for Patients with Rare Bleeding Disorders
July 20, 2021
From
Takeda Pharmaceutical Company Limited
Via
Business Wire
Moderna Extends Rally With Expanded Japanese COVID-19 Vaccine Supply Deal
July 20, 2021
Moderna, Inc. (NASDAQ: MRNA) shares appear to be going from strength to strength, and the premarket price action Tuesday suggests a positive open for the fifth straight...
Via
Benzinga
Exposures
COVID-19
Japan To Buy Additional 50M Doses Of Moderna COVID-19 Vaccine
July 20, 2021
Moderna Inc (NASDAQ: MRNA) has announced that the Ministry of Health, Labour and Welfare of Japan (MHLW) and Takeda Pharmaceutical Co Ltd (NYSE: TAK) will...
Via
Benzinga
Exposures
COVID-19
Takeda Announces the Submission of Its Corporate Governance Report to the Tokyo Stock Exchange
July 19, 2021
From
Takeda Pharmaceutical Company Limited
Via
Business Wire
< Previous
1
2
...
10
11
12
13
14
15
16
17
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.